Correction: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis

Correction: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis

Bibliographic Details
Main Authors:	Daniel Figueiredo, Inês Ribeiro, Ana Penedones, Diogo Mendes, Carlos Alves, Francisco Batel-Marques, Daniel Pereira da Silva
Format:	Article
Language:	English
Published:	BMC 2024-02-01
Series:	BMC Women's Health
Online Access:	https://doi.org/10.1186/s12905-024-02927-1

Similar Items

Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
by: Daniel Figueiredo, et al.
Published: (2023-03-01)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
by: Max Chernesky, et al.
Published: (2017-06-01)

Performance of Aptima HPV E6/E7 mRNA Test for Detection of Cervical Lesions in a Large Chinese Population
by: Zhujuan Yang, et al.
Published: (2022-11-01)

A systematic review of observational studies evaluating costs of adverse drug reactions
by: Batel Marques F, et al.
Published: (2016-08-01)

SEGURANÇA DOS MEDICAMENTOS BIOLÓGICOS OFTÁLMICOS: REVISÃO SISTEMÁTICA
by: Ana Penedones, et al.
Published: (2015-03-01)

Farmacovigilância em Portugal: Atividade da Unidade Regional do Centro
by: Francisco Batel-Marques, et al.
Published: (2015-04-01)

O Regulamento Europeu de Avaliação de Tecnologias de Saúde e o seu Potencial Impacto no Acesso ao Mercado de Medicamentos: O que Perspetivam os Profissionais da Área?
by: Diogo Mendes, et al.
Published: (2023-12-01)

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies
by: Angela Pista, et al.
Published: (2019-02-01)

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
by: Kate T Simms, et al.
Published: (2017-01-01)

A comparison between two recommendations to conduct and report systematic reviews on drug’s safety
by: Ana Penedones, et al.
Published: (2019-10-01)

Recommendations to conduct and report systematic reviews in medical literature: a scoping review
by: Ana Penedones, et al.
Published: (2019-12-01)

Yes! To Scaling Up Cervical Cancer Screening With Self-Collection: But the Cost of HPV Screening Must Be Reduced
by: Ann Marie Beddoe
Published: (2021-12-01)

Replicate Aptima VL testing detects residual viremia in most ART-treated adults
by: S. Bakkour, et al.
Published: (2017-12-01)

Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
by: Sara Fogelberg, et al.
Published: (2020-01-01)

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis.
by: Steffie K Naber, et al.
Published: (2016-01-01)

Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.
by: Sara Fogelberg, et al.
Published: (2020-01-01)

Cervical Cancer Screening and HPV Vaccination in Nepal
by: Gehanath Baral, et al.
Published: (2023-01-01)

Need for expanded HPV genotyping for cervical screening
by: Jack Cuzick, et al.
Published: (2016-12-01)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022-05-01)

Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
by: Brandon Chua, et al.
Published: (2023-03-01)

Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer
by: Tanitra Tantitamit MD, et al.
Published: (2020-05-01)

Cervical cytology and HPV in cervical cancer screening: Current and future perspectives
by: Pooja Bakshi, et al.
Published: (2023-01-01)

Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil
by: Luiz Carlos Zeferino, et al.
Published: (2018-06-01)

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program
by: Jie-Bin Lew, MPH, et al.
Published: (2017-02-01)

Erratum: Cervical Cancer Screening and HPV Vaccination in Nepal
by: Gehanath Baral, et al.
Published: (2023-01-01)

Proposal for cervical cancer screening in the era of HPV vaccination
by: Yung-Taek Ouh, et al.
Published: (2018-05-01)

False positive cervical HPV screening test results
by: Mark Schiffman, et al.
Published: (2019-06-01)

Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol
by: Sharonjit K. Dhillon, et al.
Published: (2023-02-01)

The health outcome and the costs of primary HPV testing with dual-stain cytology triage in cervical cancer screening
by: Wiebren A.A. Tjalma
Published: (2018-11-01)

Desperdício de medicamentos no ambulatório em Portugal
by: Zilda Mendes, et al.
Published: (2010-01-01)

Desperdício de Medicamentos no Ambulatório em Portugal
by: Z Mendes, et al.
Published: (2019-12-01)

HPV distribution in cervical cancer in Portugal. A retrospective study from 1928 to 2005
by: Ana Félix, et al.
Published: (2016-12-01)

Current Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers
by: Sunny S. Shah, et al.
Published: (2016-09-01)

Prevalência do HPV em mulheres rastreadas para o câncer cervical Prevalence of genital HPV infection among women screened for cervical cancer
by: Cristina Helena Rama, et al.
Published: (2008-02-01)

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
by: Megan A. Smith, et al.
Published: (2017-06-01)

Inequities in Screening and HPV Vaccination Programs and Their Impact on Cervical Cancer Statistics in Romania
by: Laurentiu Simion, et al.
Published: (2023-08-01)

Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods
by: Ai Miyoshi, et al.
Published: (2021-04-01)

O36 HPV vaccination and cervical screening in SLE patients
by: Myles Lewis, et al.
Published: (2024-03-01)

Prevention of Cervical Cancer through HPV Vaccination and Screening in Maldives
by: Sujith Kumar Mullapally, et al.
Published: (2023-01-01)

Comments on: Limitations of HPV DNA Testing in Screening of Cervical Adenocarcinomas
by: Laurence M. Vaughan, et al.
Published: (2019-06-01)